Literature DB >> 495745

Interaction of somatostatin with PTH and AVP: renal effects.

N Brautbar, B S Levine, J W Coburn, C R Kleeman.   

Abstract

Six conscious intact dogs were studied to evaluate the interactions of somatostatin (SRIF) with exogenous antidiuretic hormone arginine vasopressin (AVP). SRIF administration caused a significant increase in free water clearance compared to a vehicle-treated group: -0.91 (+/- 0.41 SD) ml/min to 0.21 (+/- 0.32 SD) ml/min in the experimental group (P less than 0.01) versus 0.21 (+/- 0.81 SD) ml/min to -0.21 (+/- 0.68 SD) ml/min in the control (P greater than 0.5). Six conscious, thyroparathyroidectomized dogs were studied to test the interaction of SRIF and parathyroid extract (PTE). There were no significant changes in the phosphaturic and hypocalciuric effects of PTE with SRIF administration. We conclude that acute systemic SRIF administration interferes with the antidiuretic action of AVP, probably at the renal-tubular level, but does not antagonize the renal actions of PTE.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 495745     DOI: 10.1152/ajpendo.1979.237.5.E428

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  4 in total

1.  Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease.

Authors:  A Lianne Messchendorp; Edwin M Spithoven; Niek F Casteleijn; Wendy A Dam; Jacob van den Born; Wouter F Tonnis; Carlo A J M Gaillard; Esther Meijer
Journal:  BMC Nephrol       Date:  2018-12-19       Impact factor: 2.388

2.  Effect of somatostatin on kidney function and vasoactive hormone systems in health subjects.

Authors:  T Tulassay; Z Tulassay; W Rascher; L Szücs; H W Seyberth; I Nagy
Journal:  Klin Wochenschr       Date:  1991-08-01

3.  Somatostatin: an endogenous peptide in the toad urinary bladder inhibits vasopressin-stimulated water flow.

Authors:  J N Forrest; S Reichlin; D B Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

4.  Effect of a Somatostatin Analogue on the Vasopressin Pathway in Patients With ADPKD.

Authors:  A Lianne Messchendorp; Bart J Kramers; Edwin M Spithoven; Katrin Stade; Esther Meijer; Ron T Gansevoort
Journal:  Kidney Int Rep       Date:  2019-05-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.